A 12-hour versus 24-hour magnesium sulfate intravenous regimen in postpartum women with preeclampsia: a randomized clinical trial
A 12-hour magnesium sulfate regimen was non-inferior to the 24-hour standard, supporting its safety and potential utility in optimizing postpartum care, especially in resource-constrained settings.
Authors
- Maria Laura Costa (ORCID: https://orcid.org/0000-0001-8280-3234)
- Maria Laura Alves de Melo Silva (ORCID: https://orcid.org/0000-0003-4968-0951)
- José Paulo de Siqueira Guida (ORCID: https://orcid.org/0000-0002-3648-6159)
- Fernanda Garanhani Surita (ORCID: https://orcid.org/0000-0003-4335-0337)
- Patricia Guimarães Custódio
Institutions
- Universidade Estadual de Campinas (UNICAMP) (BR)
Publication Details
- Journal
- Pregnancy Hypertension
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1016/j.preghy.2025.101391
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00